2017 6-month group forecast
Oct 24 (Reuters) -
Aska Pharmaceutical Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
6 Months to 6 Months to
Sep 30, 2017 Sep 30, 2017
LATEST PREVIOUS
FORECAST FORECAST
Sales 25.00 25.00
Operating 1.87 1.40
Recurring 1.99 1.50
Net 1.64 1.30
EPS 58.17 yen 46.51 yen
NOTE - Aska Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on ASKA Pharmaceutical Holdings
See all newsTable: Aska Pharmaceutical Holdings -Q1 group results
Brief: Dalton Investment Strongly Oppose Conditional Activation Of Countermeasures Announced By Aska Pharmaceutical Holdings On May 25
Brief: Aska Pharmaceutical -Plan To Put To Shareholders Proposal On Countermeasures Against Potential Large-Scale Share Purchase By Dalton And Related Parties
Table: Aska Pharmaceutical Holdings -2025/26 group results
Table: Aska Pharmaceutical Holdings -2025/26 group results